NASDAQ:IMUX

Immunic Earning Date

USA |NASDAQ |USD

IMUX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.78 $-0.82 $-0.70
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Immunic's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

IMUX Earnings Date & History Chart

IMUX Earnings & Revenue Forecast

IMUX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-0.78 $-0.94 $-0.55
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-3.96 $-4.34 $-3.34
Dec 2022 8 $-3.64 $-4.42 $-2.47

IMUX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.78 $-0.76 $-0.78
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.96 $-3.73 $-3.80
Dec 2022 0 / 0 $-3.64 $-3.70 $-3.83

IMUX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $0.00 $0.00 $0.00
Dec 2022 7 $0.00 $0.00 $0.00

IMUX Earnings Date & Revenue History

IMUX Earnings History

|
Show More
Show More

IMUX Revenue History

|
Show More
Show More

Immunic Next Earnings Date & Report

IMUX Next Earnings Date & Report Preview: Sep 2021 (FQ)

IMUX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Immunic's next quarterly earnings is $-0.78, with a low EPS estimation of $-0.94, and a high estimation of $-0.59.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.78, the last 2 month trend is $-0.72, and the 3 month trend is $-0.73.

Based on 7 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Immunic Previous Earnings Dates & Reports

IMUX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Immunic's previous earnings date was Aug 6, 2021 for its fiscal quarter ended Jun 30, 2021.

IMUX's earnings per share (EPS) was $-0.82, missing the consensus analysts forecast of $-0.67 by -22.99%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 0.75%, and higher than the same period a year before (Jun 2020) by -8.89%.

Revenues were $0.00.

The company reported a net income of $-17.93M.

Free cash flow for the quarter was $-29.02M , compared to $-12.96M last quarter and $-9.28M a year before.

IMUX ended the quarter with $1.02M in total debt, a decrease of -22.29% compared to the previous quarter, and an increase of 28.37% compared to the same quarter a year before.

IMUX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Immunic's previous annual earnings date was Feb 26, 2021 for its fiscal year ended Dec 31, 2020.

IMUX's earnings per share (EPS) was $-2.85, beating the consensus analysts forecast of $-2.86 by -0.35% , and higher than the previous year's EPS (Dec 2019) by -75.80%.

Revenues were $0.00.

The company reported a net income of $-44.02M.

Immunic reported a free cash flow of $-46.27M for its fiscal year, compared to $-28.60M a year ago.

The company ended the fiscal year with $679.00K in total debt, an increase of 30.58% compared to the previous year.